ACS	acute coronary syndrome
ACT	activated clotting time
ALL	acute lymphatic leukemia
AMI	acute myocardial infarction
AML	acute myeloid leukemia
ASA	acetylsalicylic acid
BMS	bare metal stent
CABG	coronary artery bypass graft (surgery)
CAD	coronary artery disease
CHOP	Cytoxan, Hydroxyrubicin (Adriamycin), Oncovin (Vincristine), Prednisone (chemotherapy regimen)
CI	confidence interval
CLL	chronic lymphatic leukemia
CML	chronic myeloid leukemia
CYP	cytochrome P
DAPT	dual antiplatelet therapy
DES	drug eluting stent
EU	European Union
FU	fluorouracil
GDP	guanosine 5’-diphosphate
HF	heart failure
HR	hazard ratio
hsCRP	high sensitive C-reactive protein
IL	interleukin
IVUS	intravascular ultrasound
MACCE	major adverse cardiac and cerebrovascular events
MACE	major adverse cardiac events
MI	myocardial infarction
MINOCA	myocardial infarction with nonobstructive coronary arteries
NHL	non-Hodgkin lymphoma
NSTEMI	non-ST-elevation myocardial infarction
OCT	optical coherence tomography
OR	odds ratio
QoL	quality-of-life
PCI	percutaneous coronary intervention
POBA	percutaneous old balloon angioplasty
SIR	standard incidence ratio
STEMI	ST-elevation myocardial infarction
TKI	tyrosine kinase inhibitor
US	United States
VEGF	vascular endothelial growth factor